Lon­za braces for 2024 prof­it im­pact due to Mod­er­na, Ko­di­ak man­u­fac­tur­ing cuts

Lon­za is prepar­ing for prof­it im­pact in 2024 be­cause of over­all biotech fund­ing con­straints, topped off by Mod­er­na’s con­tract can­cel­la­tion and its ex­pect­ed small­er busi­ness …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA